Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acset Indonusa Tbk (ACST) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Acset Indonusa TbkTrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Acset Indonusa Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Acset Indonusa Tbk trades at Rp87 (market cap 1.52T, 161.8K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Acset Indonusa Tbk is far larger — about 4.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Acset Indonusa Tbk is more actively traded (161.8K versus 41.7K). Which is the better fit depends on your goals.

ACSTDGNS
Market Cap
1.52T316.25B
Volume
161.8K41.7K
Lot
1.62K417
Turnover
14.08M9.66M
Average Price
87.04231.65
Value
14.08M9.66M
Indicative Equilibrium Price
87230
Indicative Equilibrium Volume
7442.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ACST
View details
DGNS
View details

About Acset Indonusa Tbk

PT Acset Indonusa Tbk (the Company) was establised based on Notarial Deed No.2 dated January 10, 1995 of Ny. Liliana Arif Gondoutomo, S.H., Notary in Bekasi.

Read more on ACST

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS